Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis Zachary BaldwinBoshen JiaoBeth Devine Systematic Review Open access 26 April 2022 Pages: 469 - 481
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare Sector Setting Sabine Michelsen RaunbakAnne Sig SørensenLars Holger Ehlers Original Research Article Open access 05 June 2022 Pages: 483 - 494
Costs and Effects of Implementing Digital Tomosynthesis in a Population-Based Breast Cancer Screening Program: Predictions Using Results from the To-Be Trial in Norway Tron Anders MogerÅsne HolenSolveig Hofvind Original Research Article Open access 07 July 2022 Pages: 495 - 507
Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain Ángel Gil de MiguelJosé María Eiros BouzaLaura Martin-Gomez Original Research Article Open access 07 March 2022 Pages: 509 - 518
Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada Elisabetta FenuVasily LukyanovMark Oppe Original Research Article Open access 26 April 2022 Pages: 519 - 537
Differences in Breast Cancer Costs by Cancer Stage and Biomarker Subtype in New Zealand Chunhuan LaoMohana MondalRoss Lawrenson Original Research Article Open access 19 February 2022 Pages: 539 - 548
Cost-Effectiveness Analysis of Intravascular Targeted Temperature Management after Cardiac Arrest in England Mehdi JavanbakhtAtefeh MashayekhiMohsen Yaghoubi Original Research Article Open access 03 May 2022 Pages: 549 - 562
Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) Instrument Matthew ReaneyVeleka AllenIacopo Olivotto Original Research Article Open access 02 June 2022 Pages: 563 - 574
Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial Matthew ReaneyPrithvi AddepalliJennifer T. Fine Original Research Article Open access 20 June 2022 Pages: 575 - 586
Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial Anh Dam TranAngela M. HongRachael L. Morton Original Research Article Open access 05 May 2022 Pages: 587 - 594
Feasibility of Deriving Health State Utilities in Mycosis Fungoides Cutaneous T-Cell Lymphoma Using Mapping Algorithms Michela MeregagliaRosanna Tarricone Original Research Article Open access 19 February 2022 Pages: 595 - 603
Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis Nafsika AfentouEmma Frewthe PREDNOS Collaborative Group, NIHR Medicines for Children Research Network Nephrology Clinical Studies Group Original Research Article Open access 22 June 2022 Pages: 605 - 617
Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis Zeki KocaataThomas WilkeHermann Einsele Original Research Article Open access 24 June 2022 Pages: 619 - 628
Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries Anna-Maria FontrierErica VisintinPanos Kanavos Correction Open access 01 July 2022 Pages: 629 - 629
